Ets-1 activates overexpression of JunB and CD30 in hodgkin's lymphoma and anaplastic large-cell lymphoma

American Journal of Pathology

Volumn 180, Issue 2, 2012, Pages 831-838

  Watanabe, Mariko ^a   Itoh, Kinji ^b   Togano, Tomiteru ^a   Kadin, Marshall E ^c   Watanabe, Toshiki ^d   Higashihara, Masaaki ^a   Horie, Ryouichi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD30 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR JUNB;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE OVEREXPRESSION; HODGKIN DISEASE; IMMUNOBLOTTING; LARGE CELL LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

ANTIGENS, CD30; BUTADIENES; ENZYME INHIBITORS; GENE KNOCKDOWN TECHNIQUES; HODGKIN DISEASE; HUMANS; JURKAT CELLS; K562 CELLS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NITRILES; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS C-JUN;

EID: 84856010651     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.10.007     Document Type: Article

References (40)

1. R. Horie, T. Watanabe CD30: expression and function in health and disease Semin Immunol 10 1998 457 470
2. R. Horie, M. Watanabe, T. Ishida, T. Koiwa, S. Aizawa, K. Itoh, M. Higashihara, M.E. Kadin, T. Watanabe The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma Cancer Cell 5 2004 353 364
3. M.A. Wasik, Q. Zhang, M. Marzec, M. Kasprzycka, H.Y. Wang, X. Liu Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches Semin Oncol 36 2009 S27 S35
4. E.F. Wagner AP-1: introductory remarks Oncogene 20 2001 2334 2335
5. L. Chang, M. Karin Mammalian MAP kinase signalling cascades Nature 410 2001 37 40
6. W. Jochum, E. Passegue, E.F. Wagner AP-1 in mouse development and tumorigenesis Oncogene 20 2001 2401 2412
7. B. Li, C. Tournier, R.J. Davis, R.A. Flavell Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation EMBO J 18 1999 420 432
8. N. Selvamurugan, S. Kwok, N.C. Partridge Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells J Biol Chem 279 2004 27764 27773
9. C.M. Robinson, S.S. Prime, S. Huntley, A.M. Stone, M. Davies, J.W. Eveson, I.C. Paterson Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation Int J Cancer 91 2001 625 630
10. X. Mao, G. Orchard, D.M. Lillington, R. Russell-Jones, B.D. Young, S.J. Whittaker Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas Blood 101 2003 1513 1519
11. V.D. Leaner, I. Kinoshita, M.J. Birrer AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets Oncogene 22 2003 5619 5629
12. M. Ohyama, Y. Hirayama, J. Tanuma, M. Hirano, I. Semba, H. Shisa, H. Hiai, K. Sugihara, M. Kitano Expressions of junB and c-fos are enhanced in 4-nitroquinoline 1-oxide-induced rat tongue cancers Pathol Int 54 2004 35 40
13. M. Watanabe, Y. Ogawa, K. Ito, M. Higashihara, M.E. Kadin, L.J. Abraham, T. Watanabe, R. Horie AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells Am J Pathol 163 2003 633 641
14. S. Mathas, M. Hinz, I. Anagnostopoulos, D. Krappmann, A. Lietz, F. Jundt, K. Bommert, F. Mechta-Grigoriou, H. Stein, B. Dorken, C. Scheidereit Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B EMBO J 21 2002 4104 4113
15. M. Watanabe, M. Sasaki, K. Itoh, M. Higashihara, K. Umezawa, M.E. Kadin, L.J. Abraham, T. Watanabe, R. Horie JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and Reed-Sternberg cells of Hodgkin lymphoma Cancer Res 65 2005 7628 7634
16. G.Z. Rassidakis, A. Thomaides, C. Atwell, R. Ford, D. Jones, F.X. Claret, L.J. Medeiros JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis Mod Pathol 18 2005 1365 1370
17. R. Horie, T. Watanabe, Y. Morishita, K. Ito, T. Ishida, Y. Kanegae, I. Saito, M. Higashihara, S. Mori, M.E. Kadin Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells Oncogene 21 2002 2493 2503
18. R.C. Bargou, F. Emmerich, D. Krappmann, K. Bommert, M.Y. Mapara, W. Arnold, H.D. Royer, E. Grinstein, A. Greiner, C. Scheidereit, B. Dorken Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells J Clin Invest 100 1997 2961 2969
19. M. Watanabe, M.Z. Dewan, M. Taira, M. Shoda, M. Honda, T. Sata, M. Higashihara, M.E. Kadin, T. Watanabe, N. Yamamoto, K. Umezawa, R. Horie IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells Lab Invest 87 2007 372 382
20. B. Zheng, P. Fiumara, Y.V. Li, G. Georgakis, V. Snell, M. Younes, J.N. Vauthey, A. Carbone, A. Younes MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival Blood 102 2003 1019 1027
21. M. Marzec, M. Kasprzycka, X. Liu, P.N. Raghunath, P. Wlodarski, M.A. Wasik Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf Oncogene 26 2007 813 821
22. M. Watanabe, Y. Ogawa, K. Itoh, T. Koiwa, M.E. Kadin, T. Watanabe, I. Okayasu, M. Higashihara, R. Horie Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma Lab Invest 88 2008 48 57
23. N.C. Andrews, D.V. Faller A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells Nucleic Acids Res 19 1991 2499
24. T.A. Kunkel, K. Bebenek, J. McClary Efficient site-directed mutagenesis using uracil-containing DNA Methods Enzymol 204 1991 125 139
25. R. Horie, K. Ito, M. Tatewaki, M. Nagai, S. Aizawa, M. Higashihara, T. Ishida, J. Inoue, H. Takizawa, T. Watanabe A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages Blood 88 1996 2422 2432
26. P.B. Staber, P. Vesely, N. Haq, R.G. Ott, K. Funato, I. Bambach, C. Fuchs, S. Schauer, W. Linkesch, A. Hrzenjak, W.G. Dirks, V. Sexl, H. Bergler, M.E. Kadin, D.W. Sternberg, L. Kenner, G. Hoefler The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling Blood 110 2007 3374 3383
27. J.S. Yordy, R.C. Muise-Helmericks Signal transduction and the Ets family of transcription factors Oncogene 19 2000 6503 6513
28. T. Nakayama, M. Ito, A. Ohtsuru, S. Naito, I. Sekine Expression of the ets-1 proto-oncogene in human colorectal carcinoma Mod Pathol 14 2001 415 422
29. Y. Ito, T. Takeda, M. Okada, N. Matsuura Expression of ets-1 and ets-2 in colonic neoplasms Anticancer Res 22 2002 1581 1584
30. F.Y. Hsu, P.B. Johnston, K.A. Burke, Y. Zhao The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner Cancer Res 66 2006 9002 9008
31. M. Watanabe, I. Kinji, T. Togano, M. Nakashima, M. Higashihara, M.E. Kadin, T. Watanabe, R. Horie Targeted repression of overexpressed CD30 downregulates NF-κB and ERK1/2 pathway in Hodgkin lymphoma cell lines Oncol Res 2012 (in press)
32. S.F. Amato, K. Nakajima, T. Hirano, T.C. Chiles Transcriptional regulation of the junB gene in B lymphocytes: role of protein kinase A and a membrane Ig-regulated protein phosphatase J Immunol 159 1997 4676 4685
33. R.T. Brown, I.Z. Ades, R.P. Nordan An acute phase response factor/NF-kappa B site downstream of the junB gene that mediates responsiveness to interleukin-6 in a murine plasmacytoma J Biol Chem 270 1995 31129 31135
34. M.R. Frazier-Jessen, C.D. Thompson, R. Brown, R. Rawat, R.P. Nordan, G.M. Feldman NF-kappaB elements contribute to junB inducibility by lipopolysaccharide in the murine macrophage cell line RAW264.7 FEBS Lett 513 2002 203 207
35. P. Coffer, M. de Jonge, A. Mettouchi, B. Binetruy, J. Ghysdael, W. Kruijer junB promoter regulation: ras mediated transactivation by c-Ets-1 and c-Ets-2 Oncogene 9 1994 911 921
36. T. Shoda, K. Fukuda, H. Uga, H. Mima, H. Morikawa Activation of mu-opioid receptor induces expression of c-fos and junB via mitogen-activated protein kinase cascade Anesthesiology 95 2001 983 989
37. B. Wasylyk, C. Wasylyk, P. Flores, A. Begue, D. Leprince, D. Stehelin The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation Nature 346 1990 191 193
38. L.R. Gottschalk, D.M. Giannola, S.G. Emerson Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites J Exp Med 178 1993 1681 1692
39. A.G. Bassuk, J.M. Leiden A direct physical association between ETS and AP-1 transcription factors in normal human T cells Immunity 3 1995 223 237
40. R.H. Palmer, E. Vernersson, C. Grabbe, B. Hallberg Anaplastic lymphoma kinase: signalling in development and disease Biochem J 420 2009 345 361